Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
32.04
-0.62 (-1.90%)
At close: Jul 19, 2024, 4:00 PM
32.09
+0.05 (0.16%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.82 billion as of July 22, 2024. Its market cap has decreased by -10.71% in one year.
Market Cap
1.82B
Enterprise Value
1.64B
1-Year Change
-10.71%
Ranking
Category
Stock Price
$32.04
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $1.51B to $1.82B, an increase of 20.38%. That is a compound annual growth rate of 4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.82B | -3.82% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.24% |
| Dec 31, 2020 | 2.06B | 36.05% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verona Pharma | 1.86B |
| NeoGenomics | 1.85B |
| Akero Therapeutics | 1.85B |
| Zai Lab | 1.85B |
| RxSight | 1.82B |
| Neumora Therapeutics | 1.80B |
| Ligand Pharmaceuticals | 1.79B |
| Veracyte | 1.77B |